title: [Enhanced recovery after Caesarean delivery: a practice survey in two French regions].
abstract: OBJECTIVE
  Although most components of an enhanced recovery programme (ERP) can be applied to caesarean delivery, it is unknown if their implementation is large in France.
  
  
  METHODS
  Structured interview by telephone or e-mailing of an anaesthetist to describe usual perioperative practice in two French regions (Provence - Alpes - Côte d'Azur [PACA] and Île-de-France [IDF]).
  
  
  METHODS
  Questionnaire related to scheduled caesarean delivery.
  
  
  RESULTS
  Response rate 74% (111/149 maternity units). Multimodal analgesia was almost universally applied and intrathecal/epidural morphine used by 86% of respondents. Oral administration of analgesic drugs was started before h24 in 50% of responding units and immediately after delivery in 7% of them. The urinary catheter was withdrawn after h24 in 71% of responding centres. Women were allowed to drink between h4 and h6 (60%), in an unlimited amount (79%). The first meal was authorised after h6 (89%) but before h24 (65%) or after recovery of bowel function (13%). Oxytocin was used in 69% of respondents and maintained postoperatively for 12 to 24hours (70% of oxytocin users). Carbetocin was used in the remaining 31%, usually without any maintenance oxytocic drug. Attributing one point to each major component of the ERP protocol (0-6), the median value was 3 (2-4). An ERP protocol was available in 14% of responding units and was associated with a shorter duration of intravenous and urinary catheters use.
  
  
  CONCLUSIONS
  The study shows that the components of an ERP are insufficiently implemented in France after caesarean delivery. Moreover, significant heterogeneity exists between maternity units and among regions.
authors: Service d'anesthésie-réanimation, hôpital Bicêtre, AP-HP, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France.
authors: A
authors: A
authors: Wyniecki
authors: M
authors: M
authors: Raucoules-Aimé
authors: J
authors: J
authors: de Montblanc
authors: D
authors: D
authors: Benhamou
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D000762:Anesthesia Recovery Period; D000773:Anesthesia, Obstetrical / Q000379:methods; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002585:Cesarean Section / Q000534:rehabilitation*; D004326:Drinking; D004750:Enteral Nutrition; D005260:Female; D005602:France; D019538:Health Care Surveys; D006771:Hospitals, Maternity / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D007407:Interviews as Topic; D007902:Length of Stay; D010121:Oxytocin / Q000627:therapeutic use; D010149:Postoperative Pain / Q000188:drug therapy; D010353:Patient Education as Topic; D019990:Perioperative Care / Q000379:methods* / Q000592:standards; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011247:Pregnancy; D020127:Recovery of Function; D011795:Surveys and Questionnaires; D014546:Urinary Catheterization / Q000706:statistics & numerical data
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010121:Oxytocin